Long COVID and Post-exertional Pulmonary Diffusion
NCT05430503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2022-06-24
Summary
Aim of investigators was to study whether abnormalities of lung diffusing capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) in long COVID may have a clinical impact in relation to exercise intolerance.
Conditions
- Long COVID
- Breathlessness
- Exercise Intolerance
- Alveolar Lung Disease
- Pulmonary Gas Exchange
Interventions
- DIAGNOSTIC_TEST
-
Lung volumes, spirometry and standard single-breath DLCO were measured at rest while combined DLNO and DLCO were measured at rest and post-exercise
DLNO and DLCO were measured at rest and 5-10 s after a bout of treadmill exercise simulating usual walking
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-24
- Primary Completion
- 2022-06-15
- Completion
- 2022-06-15
Countries
- Italy
Study Locations
More Related Trials
-
Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.
NCT04552340 ·Status: UNKNOWN
-
Responses to CPET in Subjects With Persistent Exercise Intolerance After COVID-19: an Open-Source Exercise Network
NCT05532995 ·Status: COMPLETED
-
The Long Term Effects of COVID on Pulmonary Function
NCT05077982 ·Status: COMPLETED
-
Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy
NCT06613321 ·Status: COMPLETED
-
Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease
NCT01554774 ·Status: COMPLETED
-
Long Term Outcomes of Coronavirus Disease-19 (COVID-19)
NCT04715919 ·Status: COMPLETED
-
Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease
NCT04407169 ·Status: COMPLETED
-
Biomarkers in Chronic Obstructive Pulmonary Disease (COPD)
NCT01145300 ·Status: COMPLETED
-
Impact of COVID-19 on Lung Function in COPD Patients.
NCT05770440 ·Status: RECRUITING
-
Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT07259174 ·Status: RECRUITING
-
Prognostic of Dysfunctional Breathing in Long Covid: a Follow up Study
NCT05217875 ·Status: UNKNOWN
-
Prevalence of Pulmonary Hypertension in COPD Patients
NCT00614900 ·Status: COMPLETED
-
Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias
NCT02596841 ·Status: COMPLETED
-
Diagnostic Values of C-reactive Protein and Procalcitonin in Predicting Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT03923803 ·Status: UNKNOWN
-
A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)
NCT02100332 ·Status: COMPLETED
-
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease
NCT03014609 ·Status: RECRUITING
-
Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae
NCT04519320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19
NCT04535154 ·Status: UNKNOWN
-
Biological Markers for Professional COPD
NCT03240198 ·Status: UNKNOWN
-
Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02827721 ·Status: UNKNOWN
-
Uncontrolled Postviral Asthma and Persistent Symptoms After COVID-19
NCT05919004 ·Status: COMPLETED
-
Pulmonaryhypertension in Copd at Different Levels of Smoking
NCT06031311 ·Status: UNKNOWN
-
Impact of COVID19 on Asthma Patients in Spain
NCT05064501 ·Status: WITHDRAWN
-
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196 ·Status: RECRUITING
-
Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD
NCT03287921 ·Status: COMPLETED